Swedish Orphan Biovitrum GmbH secures contract for Pharmaceutical products drug framework discount agreement in accordance with Section 130a Paragraph 8 and Section 130c Paragraph 1 of the Fifth Social Security Code - Aspaveli active ingredient Pegcetacoplan ATC L04AJ03

Germany, June 18 -- Germany based Swedish Orphan Biovitrum GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products drug framework discount agreement in accordance with Section 130a Paragraph 8 and Section 130c Paragraph 1 of the Fifth Social Security Code - Aspaveli active ingredient Pegcetacoplan ATC L04AJ03 . The value of the contract is not disclosed .

Published by HT Digital Content Services with permission from Pivotal Sources....